Mineralys Therapeutics (MLYS) Return on Capital Employed [ROCE] (2023 - 2026)
Mineralys Therapeutics (MLYS) posted Return on Capital Employed [ROCE] of -57.84% for Q2 2026, up 5.00 percentage points from -62.84% a year earlier but down 31.15 percentage points from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Mineralys Therapeutics' Return on Capital Employed [ROCE] came in at -40.74%, up 49.11 percentage points from FY2024.
- In prior years, Mineralys Therapeutics' Return on Capital Employed [ROCE] was -89.86% in FY2024 (-40.80 pp) and -49.06% in FY2023.
- Quarterly Return on Capital Employed [ROCE] has run from a low of -86.50% in Q4 2024 to a high of -16.44% in Q2 2023 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of -1.74 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 58.79 percentage points; the weakest was Q4 2024, with a drop of 53.19 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -26.69% (Q1 2026), -27.71% (Q4 2025) and -41.43% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Mineralys Therapeutics | 2.09 Bn | 2.09 Bn | - | -57.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.84% |
| Mar 31, 2026 | -26.69% |
| Dec 31, 2025 | -27.71% |
| Sep 30, 2025 | -41.43% |
| Jun 30, 2025 | -62.84% |
| Mar 31, 2025 | -75.45% |
| Dec 31, 2024 | -86.50% |
| Sep 30, 2024 | -64.24% |
| Jun 30, 2024 | -44.18% |
| Mar 31, 2024 | -37.50% |
| Dec 31, 2023 | -33.31% |
| Sep 30, 2023 | -24.72% |
| Jun 30, 2023 | -16.44% |
| Mar 31, 2023 | -19.44% |
API Access
Mineralys Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();